Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Hormone-sensitive Prostate Cancer

Clinical trial condition

Metastatic Hormone-sensitive Prostate Cancer

Explore clinical trials studying Metastatic Hormone-sensitive Prostate Cancer. Study availability and eligibility vary by location and protocol.

21 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Hormone-sensitive Prostate Cancer trial results

Completed

Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

NCT03532217

Conditions: Metastatic Hormone-sensitive Prostate Cancer
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details